Allena’s oxalate decarboxylase to treat paediatric hyperoxaluria gets US FDA orphan drug status
Allena Pharmaceuticals, Inc., a specialty biopharmaceutical company focused on developing and commercialising innovative, non-systemic, oral protein therapeutics to treat metabolic and orphan... Read More